Ingredients that will get your consignment held, the categories to check first

A held consignment is the most expensive thing that can happen to a first export order, and it is almost always avoidable.

Because a detention is not a delay. The goods sit in bonded storage accruing charges, you choose between destruction and re-export at your cost, the buyer’s confidence is gone, and a detention record attaches to your name, which means your next consignments get looked at more closely.

And the cause is nearly always known in advance. Somebody could have checked a list before the formulation was finalised, and did not.

So this article is about the categories that cause detentions, rather than a list of ingredient names, because the lists change by destination and date, and the categories do not.

This is orientation, not legal, regulatory or trade advice. Permitted, restricted and prohibited ingredient lists differ by destination and product category and change frequently. Check your specific formulation against your specific destination’s current rules with a competent regulatory consultant before you manufacture.

First: the three different reasons a shipment is held

Worth separating, because they are prevented differently.

The ingredient is not permitted in that destination. A formulation problem, fixed before manufacturing and impossible to fix after.

The ingredient is permitted but the consignment fails a limit, a contaminant, a residue, a microbiological count. A sourcing and testing problem.

Or the documentation or the label is wrong. A paperwork problem, often the easiest to fix and the most common cause of ordinary delays.

The first category is the one that destroys consignments. The rest of this article is mostly about it.

Category 1: novel foods, and this is the biggest trap

And it catches brands who did everything else correctly.

Several destinations operate a “novel food” framework: an ingredient without a documented history of significant consumption in that market, before a cut-off date, requires authorisation before it can be sold.

And this is a legal status, not a safety judgement. An ingredient eaten in India for a thousand years can be novel in another jurisdiction, because the test is consumption history there, not anywhere.

Which produces the counter-intuitive result that your most traditional, most clearly Ayurvedic ingredient can be the one that blocks the shipment, while a familiar culinary herb passes.

And the preparation matters too. A food traditionally eaten as a vegetable may be non-novel in that form and novel as a concentrated extract, because the extract is a different thing in a different quantity.

What to do: check every ingredient against the destination’s novel food status, in the form you are supplying it, before the formulation is signed off. Not the plant, the plant, the part, and the preparation.

Category 2: ingredients with pharmacological activity that triggers medicines classification

A different mechanism and a serious one.

Several destinations maintain lists of substances that may only be sold as medicines, or not at all in food supplements. An ingredient with recognised pharmacological activity can push your whole product from the food category into the medicines category, where it needs an authorisation you do not have.

And the threshold is sometimes a quantity rather than a presence, permitted below a level, a medicine above it. So the same ingredient at a higher standardisation can change your product’s legal category.

This is also where a concentrated extract differs from a traditional powder in a way that matters legally, not just commercially.

Category 3: ingredients with specific restrictions and warning requirements

Permitted, but conditional, and the conditions are where consignments fail.

Several categories attract mandatory warnings, maximum levels, or restrictions on sale to particular groups.

The pattern to watch for across destinations: ingredients with documented effects on pregnancy; ingredients affecting blood pressure, where a maximum level and a warning are typical; ingredients affecting blood clotting; ingredients with stimulant activity; ingredients with known interactions with common prescription medicines; and ingredients associated with liver signals, which have attracted increasing attention in several markets.

And the failure mode is usually not the ingredient. It is that the required warning was not on the label in the required language with the required wording.

We already print a set of these warnings as a matter of policy, liquorice and blood pressure with the glycyrrhizin content, neem in pregnancy and when trying to conceive, tulsi and conception, arjuna with “do not stop prescribed medicines”, ashwagandha and thyroid medication, giloy and long-term use, biotin and blood tests. For export, the question becomes whether our wording matches the destination’s required wording, which is a separate check.

Category 4: mineral and metal-containing preparations

Direct and unambiguous.

Products containing intentionally added metals and minerals are restricted or prohibited in most destinations, generate detentions, and attract scrutiny that extends to your entire range.

We do not make them and we would advise against attempting to export them.

Category 5: species restricted for conservation reasons

Increasingly live, and under-appreciated.

Some medicinal plant species are subject to trade controls on conservation grounds, including international conventions and national restrictions on wild collection and export.

A species in that position may require permits regardless of its safety.

And wild-collected material generally is attracting more sourcing documentation requirements from buyers and regulators alike, origin, sustainability, and legality of collection.

Category 6: animal-derived and prohibited-source components

Easy to miss because the component is often not thought of as an ingredient.

Gelatin capsule shells. Source, species, and in some markets BSE/TSE documentation.

Shellac, carmine, lactose, honey, and some excipients.

And in certain destinations, specific sourcing or certification requirements for ingestible products that go beyond declaration.

The capsule shell is the one most often forgotten, because the brand thinks about the contents.

Category 7: contaminant limits that differ from India’s

The second reason for detention, and this one survives a correct formulation.

Heavy metals, pesticide residues, mycotoxins, microbiological criteria, and in some cases solvent residues from extraction.

Limits differ between destinations, and are sometimes expressed on a different basis, per kilogram of product versus per daily dose. A product fully compliant in India can fail a destination limit without anything being wrong with it domestically.

And pesticide panels differ: a multi-residue screen covering 100 compounds does not establish compliance with a destination that regulates 400.

What to do: test against the destination’s limits, with the destination’s panel, before shipping. Not against Indian limits.

Category 8: the label and the claims

And this causes more held consignments than almost anything else, while being entirely preventable.

Claims not permitted in the destination. Most export markets are stricter than India, and a claim that passes here can block a shipment there.

Mandatory information missing, allergen declarations in the required format, nutrition declaration, the destination’s required warnings, the importer’s details, language requirements.

Wrong units or formats for nutrition and quantity declarations.

And a logo or certification mark used incorrectly, including organic marks.

The procedure that prevents all of this

Six steps, in this order, before manufacturing.

Get the destination and the product category confirmed in writing, because the rules differ by category even within one country.

Check every ingredient, in the form and quantity you will supply, against that destination’s permitted, restricted, novel and medicines lists. Every ingredient includes excipients and the capsule shell.

Check the required warnings and mandatory label information for each ingredient you keep, and get the exact required wording.

Get the destination’s contaminant limits and test against those, with their panel scope.

Have the artwork reviewed for that destination’s claim rules before plates are made.

And ask the buyer to confirm the full documentation list in writing, which we have covered separately.

This sequence costs days. A detention costs weeks, the consignment, and the relationship.

And what we do

We decline export orders where an ingredient is restricted in the stated destination rather than shipping and hoping.

This loses orders, and the reasoning is straightforward: a held consignment costs the client far more than a lost order costs us, and a detention record follows a brand into every subsequent shipment.

We also will not confirm an export delivery date before the documentation list is in hand, because a date given without it becomes a broken commitment.

If your manufacturer has never asked you which country a product is going to before quoting it, that is worth noticing.

The short version

1. A detention is not a delay, storage cost, destruction or re-export, and a record
2. The record means future consignments get examined more closely
3. And the cause is almost always knowable before manufacturing
4. Three reasons: ingredient not permitted, a limit failed, or paperwork wrong
5. The first destroys consignments and cannot be fixed after manufacturing
6. Novel food frameworks are the biggest trap
7. Novel status is a legal status, not a safety judgement
8. The test is consumption history in that market, not anywhere
9. So your most traditional ingredient can be the one that blocks the shipment
10. And a vegetable may be non-novel while its extract is novel
11. Check the plant, the part, and the preparation, not just the plant
12. Some ingredients are medicines-only in some destinations
13. And the threshold is sometimes a quantity, not a presence
14. So a higher standardisation can change your product’s legal category
15. Conditional ingredients fail on missing mandatory warnings
16. Pregnancy, blood pressure, clotting, stimulants, interactions, liver signals
17. Usually the ingredient was fine and the required wording was absent
18. Mineral and metal-containing preparations: restricted nearly everywhere
19. Conservation-restricted species may need permits regardless of safety
20. Wild-collected material now attracts sourcing documentation
21. Animal-derived components, with the capsule shell most often forgotten
22. Gelatin source and species, plus BSE/TSE documentation in some markets
23. Contaminant limits differ and are sometimes on a different basis
24. Per kilogram versus per daily dose is not the same test
25. A 100-compound pesticide panel does not clear a 400-compound regime
26. Test against the destination’s limits with the destination’s panel
27. Claims permitted in India can block a shipment elsewhere
28. Mandatory information, formats, units and language all cause holds
29. Incorrect logo or certification mark use does too
30. Confirm destination and product category in writing first
31. Check every ingredient including excipients and the shell
32. Get exact required warning wording, not an approximation
33. Review artwork for that destination before plates are made
34. And get the buyer’s documentation list in writing
35. This sequence costs days; a detention costs the consignment
36. A manufacturer who never asks the destination before quoting is worth noticing

Related guides: how to choose a contract manufacturer, supplement label compliance in India, licences for Ayurvedic manufacturing. Related reading: export documentation, what buyers actually ask for, which Indian herbal products actually sell abroad, real-time vs accelerated stability for registration, and export ke liye kya documents chahiye.